Hambalyo in Bigfish Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) la siiyay shahaadada CE ee Yurub

Waqtigan xaadirka ah, cudurku si isdaba joog ah ayuu isu bedbeddelay oo fayrasku marar badan wuu isbeddelay. Marka loo eego tirakoobyada la sii daayay Noofambar 10, tirada kiisaska COVID-19 ee adduunka oo dhan waxay kordheen in ka badan 540,000, tirada guud ee kiisaska la xaqiijiyay ayaa kor u dhaaftay 250 milyan. COVID-19 ayaa dhibaato aan horay loo arag ku haya caafimaadka iyo dhaqaalaha dadka adduunka oo dhan. Ka-hortagga cudurka faafa waqti hore iyo soo celinta kobaca dhaqaalaha ayaa ah mudnaanta koowaad ee beesha caalamka. Marka la eego ka-hortagga cudurrada dibadda, waxaa jira baahi ballaaran oo suuq ah oo loogu talagalay alaabada antigen-ka ee COVID-19.

Dhawaan, Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) by Bigfish waxaa la siiyay shahaadada CE ee Midowga Yurub. Kadib markii la helo shahaadada CE, badeecada waxaa lagu iibin karaa wadamada EU iyo wadamada aqoonsan Shahaadada CE, oo sii kobcinaysa khadka wax soo saarka ee shirkadda.

Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) by Bigfish waa sahlan tahay in lagu shaqeeyo qalab la'aan, si degdeg ahna lagu ogaado. Natiijooyinka waxaa lagu heli karaa 15 daqiiqo gudahood. Waxa kale oo ay aqoonsan kartaa caabuq degdeg ah ama hore.

Isagoo wajahaya infekshanka cusub ee coronavirus, Bigfish wuxuu diiradda saari doonaa tignoolajiyada asaasiga ah oo leh qaab shaqo oo adag oo macquul ah. Waxaan bixin doonaa badeecooyin iyo adeegyo aad u wanaagsan si aan gacan uga geysanno ka hortagga iyo xakameynta cudurrada faafa ee adduunka.